Delivery Order SPE2DB22D1200-SPE2DB25FN3MT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,097.11 to AmerisourceBergen Drug Corp for Armour Thyroid 60 mg tablets (100-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.64 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg on June 20, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Armour Thyroid 90 mg tablets in a quantity of 100 units, valued at $2,122.76. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Armour Thyroid 60 mg tablets (100-count) with a contract value of $2,045.82. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.93 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg on May 5, 2025, with completion scheduled for May 6, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, the federal government's primary source for medical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Armour Thyroid 90 mg tablets (100-count units) with a contract ceiling value of $2,847.42. This is a firm fixed-price delivery order with an ultimate completion date of March 17, 2025, and represents a non-competitive set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a $3,255.09 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Armour Thyroid 30 mg tablets. The contract has an ultimate completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 30 mg tablets. The contract has a ceiling value of $1,555.98 and an ultimate completion date of August 17, 2022. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 60 mg tablets. The contract has a firm fixed price of $1,591.56 and a period of performance through May 5, 2025. AmerisourceBergen, the prime contractor, is a for-profit organization headquartered in Conshohocken, Pennsylvania. The contract is not set-aside and was competitively awarded. As a large Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply 4,566,451,015 units of the medication Armour Thyroid 120 mg tablet in 100-count bottles. The contract has a firm fixed price and a ceiling value of $2,085.67. The period of performance runs through November 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3MTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,103.21 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 60 mg on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical commodities to support Defense Health Agency operations and other federal healthcare customers worldwide. This delivery order for thyroid hormone replacement therapy represents a routine fulfillment under the broader pharmaceutical prime vendor agreement, demonstrating the company's ongoing capability to meet federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 7/30/25 |